SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Omeros
An SI Board Since March 2010
Posts SubjectMarks Bans Symbol
464 28 0 OMER
Emcee:  Bradpalm1 Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
214>>My thoughts are that this program, the MASP-2 mAb program, will be the hBiomaven-3/10/2014
213My thoughts are that this program, the MASP-2 mAb program, will be the huge valuBiotech Jim-3/10/2014
212From the PR ..... " Prof. Remuzzi's laboratories have previously shownHoward Williams-3/10/2014
211Omeros Announces Positive OMS721 Data in Serum from Patients with aHUS - PhaseHoward Williams-3/10/2014
2103 Things to Know About Omeros CorporationBy Catherine Shaffer Howard Williams-3/7/2014
209Omeros Reports Additional Positive Data from its OMS824 Phase 2a Schizophrenia CHoward Williams-3/6/2014
208 Re: Omeros (OMER) - A Seattle biotech Omeros Closes $32 Million Debt Financing,Howard Williams-3/5/2014
207Motley Fool says ...... Today's Biggest Biotech Stories: Dendreon, AbbVie, Howard Williams-3/4/2014
206Omeros Submits IND to Advance OMS721 Phase 2 Clinical Program -- Successful PhHoward Williams-3/4/2014
205Nasdaq biotechs in general were nailed Friday. IBB was down 2.84% on the day.Howard Williams-3/1/2014
204 Omeros to Present at Cowen and Company 34th Annual Health Care Conference SEATHoward Williams-2/26/2014
203Three small biotechs ....... including OMER ************************************Howard Williams-2/24/2014
202Omeros Announces Enrollment in Second Phase 2 Clinical Trial with OMS824 -- PDHoward Williams-2/19/2014
201Omeros Reports Additional Positive Phase 1 Clinical Data for OMS824 for the TreaHoward Williams-2/11/2014
200A very interesting report on drug launches in 2014 http://www.fdanews.com/ext/rHoward Williams-2/10/2014
199Huntington's Disease Society of America website info .... HDSA's "Howard Williams-2/6/2014
198FDA Grants Fast Track Designation to Omeros' OMS824 Huntington's DiseaseHoward Williams-2/5/2014
197Omeros Announces Positive Data After Completion Of Dosing In Phase 1 Clinical TrHoward Williams-2/3/2014
196That caught me eye too. I may have to buy back in again, on a pull back, if it hKhris Smith-1/30/2014
195Schizophrenia in the news, thanks to boomertree2 on the PVCT board *************Howard Williams-1/30/2014
194 Omeros Reports Positive Results from OMS824 Phase 2a Clinical Trial - Data expaHoward Williams-1/29/2014
193 FDA Grants Orphan Drug Designation to Omeros' OMS721 for Complement-MediateHoward Williams-12/18/2013
192 Omeros to Present at Oppenheimer 24th Annual Healthcare Conference SEATTLE, DeHoward Williams-12/5/2013
191In OMER's PR two days ago, they said, "pupil constriction of at least 3Howard Williams-11/21/2013
190Steve, I've bought more in the last few days, all of it at higher than the cHoward Williams-11/21/2013
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News